What are the risk factors for Diabetes?

['Sel i usebter-agi']

D acu-ten yimgan n umihi n sskeṛ?

Llan aṭas n yimgan n umihi i waṭṭan n sskeṛ, gar-asen:

1. Amezruy n twacult: Ma yella yiwen seg imawlan- ik neɣ seg watmaten- ik yuḍen sskeṛ, d ayen ara k-yessegrirben.

2. Leɛmer: Amihi n waṭṭan n sskeṛ n ṣṣenf wis 2 yettzid skud tettedduḍ ad timɣureḍ, ladɣa mbeɛd 45 iseggasen.

3. Taẓayt: Ma tẓeyyeḍ neɣ ma tẓeyyeḍ aṭas, tzemreḍ ad tḍurrneḍ waṭṭan-a.

4. Aɣbel n tikli: Axuṣṣ n tikli tezmer ad yesnerni amihi-inek.

5. Tawsit neɣ tawsit: Kra n yegrawen n yegduden, am wid n Marikan n Tefriqt, wid n Marikan n Spenyul, Imezdaɣ n Marikan d wid n Marikan n Asya, sɛan amihi meqqren n waṭṭan n sskeṛ n ṣṣenf wis 2.

6. Aṭṭan n sskeṛ n tlawin yellan s tadist: Tilawin i yuḍnen aṭṭan n sskeṛ n tlawin yellan s tadist, yezmer lḥal ad tent-yeṭṭef sskeṛ n ṣṣenf wis 2 mi ara awḍent ɣer zdat.

7. Aṭṭan n tmellalin timseksumin: Tilawin yuḍnen aṭṭan-a ttilint deg umihi meqqren n waṭṭan n sskeṛ n ṣṣenf wis 2.

8. Aṭṭan n ubeddel n uksum: D wa i d aṭṭan i d-yettawin s waṭas lehlak n sskeṛ n ṣṣenf wis 2.

9. Akeyyef: Akeyyef yezmer ad yesnerni tuṭṭfa n insulin, ayen i d-yettawin ssebba n sskeṛ n ṣṣenf wis 2.

10. Aṭṭan n sskeṛ: Win yesεan aṭṭan n sskeṛ, neɣ win yesεan deg idammen- is ugar n wayen ilaqen, yezmer ad t- yuɣ waṭṭan n sskeṛ wis sin.

11. Taẓeyt n llufan-nni tamecṭuḥt: Iṭufanen i d-ilulen s taẓeyt tamecṭuḥt, yezmer ad ten-yeṭṭef waṭṭan n sskeṛ n ṣṣenf wis 2 mi ara imɣuren.

12. Tanezzayt n yidammen: Ma tesεiḍ tanezzayt n yidammen, tettawi- d srid ɣer waṭas n liḥalat n sskeṛ n ṣṣenf wis sin.

13. Aswir n cholesterol d triglycerides ur nṣeḥḥa ara: Aswir εlayen n triglycerides d uswir n cholesterol HDL (ayen yelhan) ixuṣṣen, rennun-d amihi n waṭṭan n sskeṛ n ṣṣenf wis 2.

14. Anezwu n nnefs: Wid yesεan anezwu n nnefs deg yiḍes, yezmer ad ten-yeṭṭef waṭṭan n sskeṛ n ṣṣenf wis sin.

15. Sstres: Sstres am wa yezmer ad yesnerni amihi n waṭṭan n sskeṛ n ṣṣenf wis sin.

16. Kra n ddwawi: Kra n ddwawi, am wid yessexdamen isṭiryuṭen d wid yessexdamen ddwawi i d-yettaken lehlakat n wallaɣ, zemren ad ssemɣaren amihi n waṭṭan n sskeṛ n ṣṣenf wis 2.

17. Asnefli: Asnefli amezzay yezmer ad yesnerni amihi n waṭṭan n sskeṛ n ṣṣenf wis 2.

18. Tudert n usgunfu: Tudert n usgunfu tezmer ad ternu amihi n waṭṭan n sskeṛ n ṣṣenf wis sin.

19. Učči yeččuren d zzit d tikaluṛyin: učči yeččuren d zzit ur nelhi d tikaluṛyin yezmer ad yesnerni amihi n waṭṭan n sskeṛ n ṣṣenf wis sin.

20. Tissit n larkul: Tissit n larkul s waṭas tezmer ad ternu amihi n waṭṭan n sskeṛ n ṣṣenf wis sin.

21. Iɣimi: Iɣimi ur d-yettak ara ddeqs n wakud yezmer ad yesnerni amihi n waṭṭan n sskeṛ n ṣṣenf wis 2.

22. Asluɣu n ubeḥri: Asluɣu n ubeḥri yezmer ad yesnerni amihi n waṭṭan n sskeṛ n ṣṣenf wis 2.

23. Kra n waṭṭanen: Kra n waṭṭanen am waṭṭan n tgezzayt C, zemren ad snernin amihi n waṭṭan n sskeṛ n ṣṣenf wis 2.

24. Aswir εlayen n homocysteine: Aswir εlayen n homocysteine, yiwen n usid amini, yezmer ad yesnerni amihi n waṭṭan n sskeṛ n ṣṣenf wis 2.

25. Aswir εlayen n uric acid: Aswir εlayen n uric acid, d afaris n usexsi, yezmer ad yesnerni amihi n waṭṭan n sskeṛ n ṣṣenf wis 2.

26. Aswir εlayen n C-reactive protein: Aswir εlayen n C-reactive protein, d amatar n tnefsit, yezmer ad yesnerni amihi n waṭṭan n sskeṛ n ṣṣenf wis 2.

27. Aswir εlayen n fibrinogen: Aswir εlayen n fibrinogen, d taṛbut yettekkan deg usemmiḍ n yidammen, yezmer ad yesnerni amihi n waṭṭan n sskeṛ n ṣṣenf wis 2.

28. Aswir εlayen n PAI-1: Aswir εlayen n PAI-1, d abelluḍ yettekka deg usemmiḍ n yidammen, yezmer ad yesnerni amihi n waṭṭan n sskeṛ n ṣṣenf wis 2.

29. Aswir εlayen n leptin: Aswir εlayen n leptin, d ahurmun yettekkan deg usefrek n laẓ, yezmer ad yesnerni amihi n waṭṭan n sskeṛ n ṣṣenf wis 2.

30. Aswir εlayen n resistin: Aswir εlayen n resistin, d ahurmun yettekka deg tuṭṭfa n insulin, yezmer ad yesnerni amihi n usnulfu n

['Tiɣbula']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

King WM, Saseen JJ, Anderson SL: Characterization of diabetes risk factors in patients prescribed chronic statin therapy. Ther Adv Chronic Dis. 2014, 5 (5): 206-11.

Bielinski SJ, Pankow JS, Rasmussen-Torvik LJ, Bailey K, Li M, Selvin E, Couper D, Vazquez G, Brancati F: Strength of association for incident diabetes risk factors according to diabetes case definitions: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2012, 175 (5): 466-72.

Gangwisch JE, Gross R, Malaspina D: Differential Associations Between Depression, Risk Factors for Insulin Resistance and Diabetes Incidence in a Large U.S. Sample. Isr J Psychiatry Relat Sci. 2015, 52 (2): 85-90.

Leiva AM, Martínez MA, Petermann F, Garrido-Méndez A, Poblete-Valderrama F, Díaz-Martínez X, Celis-Morales C: [Risk factors associated with type 2 diabetes in Chile]. Nutr Hosp. 2018, 35 (2): 400-407.

Chatterjee R, Maruthur NM, Edelman D: Novel Risk Factors for Type 2 Diabetes in African-Americans. Curr Diab Rep. 2015, 15 (12): 103.

Higa S, Maesato A, Ishigaki S, Suenari K, Chen YJ, Chen SA: Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation. Card Electrophysiol Clin. 2021, 13 (1): 63-75.

Brodalko B: [Diabetes risk factors in the Regional Railway Hospital in Lublin, described on the basis of medical documentation]. Wiad Lek. 2000, 53 (5-6): 255-61.

['Anfafad: amejjay']

['Asmel-a web yettunefk-d kan i yiswiyen n uselmed d usissen, ur d-yettak ara iwellihen imejjayen neɣ isefka udmawanen.']

['Isallen i d-yettunefken ur ilaq ara ad ttwasqedcen i usebded neɣ i usemḥi n kra n wugur n tezmert neɣ aṭṭan, yerna wid yettnadin ɣef yiwellihen imsujjiyen udmawanen yessefk ad ẓren amejjay yesɛan turagt.']

['Ttxil-k ẓer belli azeṭṭa amseddayan i d-yettaken tiririyin i tuttriwin, ur iṣeḥḥa ara mliḥ ma yella d ayen yerzan uḍḍun. D amedya, amḍan n yimdanen yettwaḍḍfen s kra n waṭṭan.']

['Ssutur dima ṛṛay n ṭṭbib-ik neɣ n kra n umejjay-nniḍen ara iwalmen ɣef waṭṭan-ik. Ɣur-k ad tḥeqreḍ ṛṛay n ṭṭbib amsadur neɣ ad tεeṭṭleḍ deg usuter-is ɣef lǧal n kra i teɣriḍ deg usmel-a. Ma tɣileḍ ahat tesεiḍ liḥala n tεeǧlanit deg tezmert, siwel 911 neɣ ṛuḥ ɣer texxamt n tεeǧlanit i d-iqerben. Ulac assaɣ gar ṭṭbib d umuḍin i d-yettnulfun s usmel-a neɣ aseqdec-is. BioMedLib neɣ ixeddamen-is, neɣ kra n win yettekkiyen deg usmel-a, ur d-ttaken ara yakk kra n yisumren, s wawal neɣ s usemres, ɣef ayen yerzan isallen i d-yettunefken dagi neɣ aseqdec-is.']

['Anekcum: azref n uḍfar']

['Asaḍuf n umeskar n yizerfan n wemdan n alfin (Digital Millennium Copyright Act) n 1998, 17 U.S.C. § 512 (DMCA) yettak-d ttawil i yimeskaren n yizerfan n wemdan i yumnen belli ayen i d-yettbanen deg Internet yettḍurru izerfan-nsen ddaw usaḍuf n umeskar n yizerfan n wemdan n Marikan. ']

['Ma tumneḍ s wul yelhan belli kra n taɣult neɣ taɣawsa yettwafken deg unermes-nneɣ neɣ deg yiqeddacen-nneɣ tegzem azref-ik n uḥraz, tzemreḍ (neɣ amsedday-ik) ad aɣ-d-tazneḍ izen akken ad nessuter asuffeɣ n taɣult neɣ n taɣawsa-nni, neɣ ad nessader tuqqna ɣer-s. ']

['Isental yessefk ad ttwazen s tira s yimayl (ẓer asebter "Contact" i tansa n yimayl).']

['DMCA teḥwaǧ isalli-inek n tukksa n yizerfan yettwanekṛen ad d-yeglu s yisallen-a: (1) asegzi n umahil yettwaḥerzen s yizerfan yettwanekṛen i d-yettwanekren; (2) asegzi n uḍris yettwanekren d yisallen ara aɣ-yeǧǧen ad d-naf uḍris-nni; (3) isallen n usiwel inek, ladɣa tansa-inek, uṭṭun n tilifun d tansa imayl; (4) awal sɣur-k d akken tumneḍ s wayen yelhan belli aḍris-nni s wamek i d-tettcetkiḍ ur yettwasemres ara sɣur bab n yizerfan, neɣ amesten-is, neɣ s useqdec n kra n usaḍuf; ']

['(5) yiwet n tseddi sɣur-k, yettwatten s uḥasef n lekdeb, d akken isallen yellan deg uzenzi d iṣeḥḥan u tesεiḍ azref ad tesseḍruḍ izerfan umeskar i d-yeqqaren ttwarẓen; ']

['akked (6) azmul n tfekka neɣ n tuqqna tagensit n bab n yizerfan neɣ n umdan yettwafernen ad yexdem s yisem n bab n yizerfan. ']

['Ma ur d-terriḍ ara isallen-agi akk, yezmer ad d-yeglu s uεeṭṭel deg usefrek n ucetki-inek.']

['Assaɣ']

['Ttxil-k azen-aɣ-d imayl ma tesεiḍ asteqsi / asumer.']

What are the risk factors for diabetes?

There are several risk factors for diabetes, including:

1. Family history: Having a parent or sibling with diabetes increases your risk.

2. Age: The risk of type 2 diabetes increases as you get older, especially after age 45.

3. Weight: Being overweight or obese increases your risk.

4. Physical inactivity: Lack of exercise can increase your risk.

5. Race or ethnicity: Certain ethnic groups, such as African Americans, Hispanic Americans, Native Americans, and Asian Americans, have a higher risk of developing type 2 diabetes.

6. Gestational diabetes: Women who have had gestational diabetes during pregnancy are at higher risk of developing type 2 diabetes later in life.

7. Polycystic ovary syndrome: Women with this condition have a higher risk of developing type 2 diabetes.

8. Metabolic syndrome: This cluster of conditions, including high blood pressure, high cholesterol, and large waist circumference, increases the risk of type 2 diabetes.

9. Smoking: Smoking can increase insulin resistance, which can lead to type 2 diabetes.

10. Prediabetes: Having prediabetes, or higher than normal blood sugar levels, increases the risk of developing type 2 diabetes.

11. Low birth weight: Babies with low birth weight have a higher risk of developing type 2 diabetes later in life.

12. High blood pressure: Having high blood pressure increases the risk of developing type 2 diabetes.

13. Abnormal cholesterol and triglyceride levels: High levels of triglycerides and low levels of HDL (good) cholesterol increase the risk of type 2 diabetes.

14. Sleep apnea: People with sleep apnea have an increased risk of developing type 2 diabetes.

15. Stress: Chronic stress can increase the risk of developing type 2 diabetes.

16. Certain medications: Some medications, such as steroids and antipsychotics, can increase the risk of developing type 2 diabetes.

17. Inflammation: Chronic inflammation can increase the risk of developing type 2 diabetes.

18. Sedentary lifestyle: A sedentary lifestyle can increase the risk of developing type 2 diabetes.

19. High-fat, high-calorie diet: Consuming a diet high in unhealthy fats and calories can increase the risk of developing type 2 diabetes.

20. Alcohol consumption: Excessive alcohol consumption can increase the risk of developing type 2 diabetes.

21. Sleep deprivation: Inadequate sleep can increase the risk of developing type 2 diabetes.

22. Air pollution: Exposure to air pollution can increase the risk of developing type 2 diabetes.

23. Certain infections: Certain infections, such as hepatitis C, can increase the risk of developing type 2 diabetes.

24. High levels of homocysteine: High levels of homocysteine, an amino acid, can increase the risk of developing type 2 diabetes.

25. High levels of uric acid: High levels of uric acid, a waste product, can increase the risk of developing type 2 diabetes.

26. High levels of C-reactive protein: High levels of C-reactive protein, a marker of inflammation, can increase the risk of developing type 2 diabetes.

27. High levels of fibrinogen: High levels of fibrinogen, a protein involved in blood clotting, can increase the risk of developing type 2 diabetes.

28. High levels of PAI-1: High levels of PAI-1, a protein involved in blood clotting, can increase the risk of developing type 2 diabetes.

29. High levels of leptin: High levels of leptin, a hormone involved in appetite regulation, can increase the risk of developing type 2 diabetes.

30. High levels of resistin: High levels of resistin, a hormone involved in insulin resistance, can increase the risk of developing

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.